![](https://dailybusinessjournal.com/wp-content/uploads/2020/08/pexels-chokniti-khongchum-3938023-1118x400.jpg)
Reading Time: 2 minutes Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials: Ampion Phase I clinical trial for intravenous (“IV”) treatment of COVID-19 patients:The initial safety Read more…
Recent Comments